[Ioversol 300: clinical study in pediatric intravenous urography].
The efficacy and safety of Optiray (Ioversol), a new low osmolar non ionic contrast agent, were evaluated in an open trial for pediatric intravenous urography. At a concentration of 30% iodine, Optiray had a good diagnostic efficacy and was found to be well tolerated.
Montagne
J
J
Service d'Imagerie Médicale, Hôpital d'enfants Armand Trousseau, Paris.
Adamsbaum
C
C
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003287:Contrast Media; D005260:Female; D006801:Humans; D007223:Infant; D007275:Injections, Intravenous; D007674:Kidney Diseases / Q000000981:diagnostic imaging; D008297:Male; D014283:Triiodobenzoic Acids / Q000008:administration & dosage; D001745:Urinary Bladder Diseases / Q000000981:diagnostic imaging; D014567:Urography / Q000379:methods*; D014570:Urologic Diseases / Q000000981:diagnostic imaging
D003287:Contrast Media; D014283:Triiodobenzoic Acids; C054871:ioversol
Ioversol 300: étude clinique en urographie intraveineuse pédiatrique.